FDA GFI, Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency, 04/21 Anna Sandberg2021-09-29T13:40:23+00:00September 29th, 2021| About the Author: Anna Sandberg